There’s a lot to be optimistic about in the Services sector as 2 analysts just weighed in on Kansas City Southern (KSU) and UnitedHealth (UNH) with bullish sentiments.
Kansas City Southern (KSU)
In a report released today, Jason Seidl from Cowen & Co. maintained a Buy rating on Kansas City Southern, with a price target of $134. The company’s shares opened today at $107.47.
According to TipRanks.com, Seidl is a 5-star analyst with an average return of 12.9% and a 66.4% success rate. Seidl covers the Services sector, focusing on stocks such as Covenant Transportation Group, Expeditors International, and Echo Global Logistics.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Kansas City Southern with a $121.55 average price target, a 13.1% upside from current levels. In a report issued on January 15, Loop Capital Markets also maintained a Buy rating on the stock with a $132 price target.
See today’s analyst top recommended stocks >>
UnitedHealth (UNH)
In a report released today, Steven Halper from Cantor Fitzgerald reiterated a Buy rating on UnitedHealth, with a price target of $310. The company’s shares opened today at $262.60.
Halper said:
“. We are reiterating our Overweight rating and $310 price target on UNH shares. Before the market open on the company reported solid 4Q18 results. Given management’s comments on its conference call, we are adjusting our quarterly 2019 EPS estimates to reflect a stronger 1Q19 bottom line due to a lower tax rate assumption. Specifically, we are increasing our 1Q19 adjusted EPS estimate to $3.55 from $3.50 while reducing our 2Q19 estimate to $3.57 from $3.63. Our 4Q19 EPS estimate has also increased (to $3.62 from $3.60). Consistent with management’s remarks, 1H19 accounts for roughly 48% of our full- year 2019 adjusted EPS estimate of $14.65 (unchanged).”
According to TipRanks.com, Halper is a top 100 analyst with an average return of 17.9% and a 62.8% success rate. Halper covers the Services sector, focusing on stocks such as WellCare Health Plans, Hms Holdings Corp, and Tivity Health Inc.
UnitedHealth has an analyst consensus of Strong Buy, with a price target consensus of $308.90, which is a 17.6% upside from current levels. In a report issued on January 4, Barclays also maintained a Buy rating on the stock with a $279 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
